Registration Dossier

Toxicological information


Currently viewing:

Administrative data

Description of key information

The substance is not mutagenic and no hyperplasia and/or pre-neoplastic lesions were observed in the dermal sub-chronic repeated dose toxicity study.

Key value for chemical safety assessment

Additional information

Justification for classification or non-classification

Based on the available data, MDEA is considered to be non-carcinogenic; therefore classification according to Directive 67/548/EEC and EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008 is not warranted.